Insulet Corp. Files 10-Q for Q2 2024
Ticker: PODD · Form: 10-Q · Filed: 2024-08-09T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, medical-devices
TL;DR
INSULET CORP 10-Q FILED: Q2 2024 FINANCIALS OUT
AI Summary
Insulet Corp. reported its financial results for the period ending June 30, 2024. The company's filing details its financial position and performance, including various financial metrics and disclosures relevant to its operations in surgical and medical instruments.
Why It Matters
This 10-Q filing provides investors and analysts with a detailed look into Insulet Corp.'s financial health and operational performance during the second quarter of 2024.
Risk Assessment
Risk Level: medium — As a medical device company, Insulet Corp. faces risks related to product development, regulatory approvals, market competition, and reimbursement policies.
Key Numbers
- N/A — Revenue (Specific revenue figures are not detailed in the provided header information.)
- N/A — Net Income (Specific net income figures are not detailed in the provided header information.)
- N/A — Total Assets (Specific total asset figures are not detailed in the provided header information.)
Key Players & Entities
- INSULET CORP (company) — Filer
- 0001145197-24-000039 (filing_id) — Accession Number
- 20240630 (date) — Period of Report
- 20240809 (date) — Filed as of Date
- 3841 (sic_code) — Standard Industrial Classification
- DE (state) — State of Incorporation
- 978-600-7000 (phone_number) — Business Phone
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20240630, indicating the second quarter of 2024.
When was this 10-Q filing submitted to the SEC?
The filing was submitted on 20240809.
What is Insulet Corp.'s Standard Industrial Classification (SIC) code?
Insulet Corp.'s SIC code is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
In which state was Insulet Corp. incorporated?
Insulet Corp. was incorporated in Delaware (DE).
What is the business address and phone number for Insulet Corp.?
The business address is 100 Nagog Park, Acton, MA 01720, and the business phone number is 978-600-7000.
From the Filing
0001145197-24-000039.txt : 20240809 0001145197-24-000039.hdr.sgml : 20240809 20240808175044 ACCESSION NUMBER: 0001145197-24-000039 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 88 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240809 DATE AS OF CHANGE: 20240808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 241189846 BUSINESS ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-600-7000 MAIL ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 10-Q 1 podd-20240630.htm 10-Q podd-20240630 false 2024 Q2 0001145197 December 31 http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations 0.0044105 http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure podd:notice podd:day iso4217:USD podd:option 0001145197 2024-01-01 2024-06-30 0001145197 2024-08-01 0001145197 2024-06-30 0001145197 2023-12-31 0001145197 us-gaap:NonrelatedPartyMember 2024-06-30 0001145197 us-gaap:NonrelatedPartyMember 2023-12-31 0001145197 us-gaap:RelatedPartyMember 2024-06-30 0001145197 us-gaap:RelatedPartyMember 2023-12-31 0001145197 us-gaap:NonrelatedPartyMember 2024-04-01 2024-06-30 0001145197 us-gaap:NonrelatedPartyMember 2023-04-01 2023-06-30 0001145197 us-gaap:NonrelatedPartyMember 2024-01-01 2024-06-30 0001145197 us-gaap:NonrelatedPartyMember 2023-01-01 2023-06-30 0001145197 us-gaap:RelatedPartyMember 2024-04-01 2024-06-30 0001145197 us-gaap:RelatedPartyMember 2023-04-01 2023-06-30 0001145197 us-gaap:RelatedPartyMember 2024-01-01 2024-06-30 0001145197 us-gaap:RelatedPartyMember 2023-01-01 2023-06-30 0001145197 2024-04-01 2024-06-30 0001145197 2023-04-01 2023-06-30 0001145197 2023-01-01 2023-06-30 0001145197 us-gaap:CommonStockMember 2024-03-31 0001145197 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001145197 us-gaap:RetainedEarningsMember 2024-03-31 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001145197 2024-03-31 0001145197 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001145197 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001145197 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001145197 us-gaap:CommonStockMember 2024-06-30 0001145197 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001145197 us-gaap:RetainedEarningsMember 2024-06-30 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001145197 us-gaap:CommonStockMember 2023-03-31 0001145197 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001145197 us-gaap:RetainedEarningsMember 2023-03-31 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001145197 2023-03-31 0001145197 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001145197 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001145197 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001145197 us-gaap:CommonStockMember 2023-06-30 0001145197 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001145197 us-gaap:RetainedEarningsMember 2023-06-30 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001145197 2023-06-30 0001145197 us-gaap:CommonStockMember 2023-12-31 0001145197 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001145197 us-gaap:RetainedEarningsMember 2023-12-31 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001145197 us-gaap:CommonSt